GRNAW | GreenLight Biosciences Holdings Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0220 - 0.0220
52 Week Range	0.0220 - 0.0220
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	550
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	N/A
Sector	Healthcare
Industry	Biotechnology
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	280
Country	USA
Website	GRNAW

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

GRNAW's peers: LFLYW, DRTSW, COEPW

*Chart delayed

Analyzing fundamentals for GRNAW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see GRNAW Fundamentals page.

Watching at GRNAW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on GRNAW Technicals page.